The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference product, per the document, and they shouldn’t suggest that a biosimilar is ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sesen today announced the launch of TrialS, a next generation regulatory ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 (approx ₹ 2,200) per week, as it seeks ...

Neupril, a United States-based supplement company, announces serving over one million customers with its ...

Front-of-Pack (FOP) labels provide exactly this by offering quick, visible guidance that helps people identify foods high in ...

Discover the best fever reducers, recommended by doctors. We reviewed top options like Tylenol, Genexa, and Advil to find safe, effective relief.

Danish drugmaker Novo Nordisk ($NVO) launched its blockbuster diabetes treatment Ozempic (semaglutide injection) in India at ...